Inhibiting sphingosine kinase 2 derived-sphingosine-1-phosphate ameliorates psoriasis-like skin disease via blocking th17 differentiation of naïve CD4 T lymphocytes in mice

Sun Hye Shin, Kyung Ah Cho, Soojung Hahn, Younghay Lee, Yu‑Hee Kim, So Youn Woo, Kyung Ha Ryu, Woo Jae Park, Joo Won Park

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Sphingosine-1-phosphate (S1P) is a signalling sphingolipid metabolite that regulates important cell processes, including cell proliferation and apoptosis. Circulating S1P levels have been reported to be increased in patients with psoriasis relative to healthy patients. The aim of this study was to examine the potency of S1P inhibition using an imiquimod-induced psoriasis mouse model. Both topical ceramidase and sphingosine kinase 1/2 inhibition, which blocks S1P generation, alleviated imiquimod-induced skin lesions and reduced the serum interleukin 17-A levels induced by application of imiquimod. These treatments also normalized skin mRNA levels of genes associated with inflammation and keratinocyte differentiation. Inhibition of sphingosine kinase 2, but not sphingosine kinase 1, diminished levels of suppressor of cytokine signalling 1 and blocked T helper type 17 differentiation of naïve CD4+ T cells; imiquimod-induced psoriasis-like skin symptoms were also ameliorated. These results indicate the distinct effects of sphingosine kinase 1 and sphingosine kinase 2 inhibition on T helper type 17 generation and suggest molecules that inhibit S1P formation, including ceramidase and sphingosine kinase 2 inhibitors, as novel therapeutic candidates for psoriasis.

Original languageEnglish
Pages (from-to)594-601
Number of pages8
JournalActa Dermato-Venereologica
Volume99
Issue number6
DOIs
StatePublished - May 2019

Bibliographical note

Publisher Copyright:
© 2019 Acta Dermato-Venereologica.

Keywords

  • CD4+ T lymphocyte
  • Psoriasis

Fingerprint

Dive into the research topics of 'Inhibiting sphingosine kinase 2 derived-sphingosine-1-phosphate ameliorates psoriasis-like skin disease via blocking th17 differentiation of naïve CD4 T lymphocytes in mice'. Together they form a unique fingerprint.

Cite this